About Kernal Biologics, Inc.
KernalBio creates mRNA therapies that instruct specific cells on how to make their own medicine
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2016
- Company type
- Privately Held
Kernal creates mRNA therapies to cure severe diseases including cancer. Our mRNA therapies instruct specific cells on how to make their own drugs. With roots at MIT, Harvard and Big Pharma, our team previously built a successful Biotech company and has deep expertise in mRNA space.
Specialties
- synthetic biology
- RNA design
- immunotherapy
- covid-19
- cancer
- and mRNA therapy
Company locations
700 Main St, Cambridge, Massachusetts 02139, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 4,981
- People linked to this company
- 21
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.